Lumen, ‘s werelds eerste draagbare metabolisme-tracker erkend voor prestaties op het gebied van screening, monitoring en diagnostiek

NEW YORK–(BUSINESS WIRE)–CB Insights heeft Lumen, het bedrijf achter ‘s werelds eerste apparaat voor het meten van het metabolisme via de adem, uitgeroepen tot zijn derde jaarlijkse Digital Health 150, waarin de 150 meest veelbelovende particuliere digitale gezondheidsbedrijven ter wereld worden getoond. De Digital Health 150 van dit jaar werd live onthuld tijdens het jaarlijkse Future of Health-evenement van CB Insights.

Het Digital Health 150-cohort 2021 heeft sinds 2016 ongeveer $ 14,9 miljard aan totale financiering opgehaald in 522 deals, en omvat startups in verschillende investeringsstadia van ontwikkeling, van een vroeg stadium tot goed gefinancierde eenhoorns. Bedrijven zijn dit jaar startups die werken aan data-integratie en -analyse, hybride virtuele / persoonlijke zorg, digitale therapieën, klinische intelligentie en meer.

Lumen Named to the 2021 CB Insights Digital Health 150 — List of Most Innovative Digital Health Startups

Lumen, the world’s first portable metabolism tracker recognized for achievements in screening, monitoring and diagnostics

NEW YORK–(BUSINESS WIRE)– CB Insights named Lumen , the company behind the world’s first metabolism measurement device through the breath, to its third annual Digital Health 150, which showcases the 150 most promising private digital health companies in the world. This year’s Digital Health 150 was unveiled live during CB Insights’ annual Future of Health event.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20211209005668/en/

Lumen metabolism tracking (Photo: Lumen)

The 2021 Digital Health 150 cohort has raised roughly $14.9B in aggregate funding across 522 deals since 2016, and includes startups at various investment stages of development, from early-stage to well-funded unicorns. Companies this year include startups working on data integration & analytics, hybrid virtual / in-person care, digital therapeutics, clinical intelligence, and more.

“This year’s Digital Health 150 is one of our most expansive yet, spotlighting 16 categories including virtual care, clinical trials tech, and workflow automation, as well as adding new categories such as home health tech and computer-aided imaging,” said Brian Lee, SVP of CB Insights’ Intelligence Unit. “Last year’s class has seen more than 20 exits, raised an additional $18.6B in aggregate funding, and announced over 250 partnerships since being recognized, and we’re excited to see the future success of this year’s winners.”

“We’re thrilled to be recognized as an innovative leader in the digital health space by CB Insights. Our mission is to make people metabolically healthier through our groundbreaking technology as we grow towards becoming the largest health platform of 1 million metabolism measurements a month,” says Daniel Tal Mor, CEO and Co-founder of Lumen.

Through an evidence-based approach, the CB Insights research team selected the Digital Health 150 from a pool of over 11,000 companies, including applicants and nominees. They were chosen based on several factors, including data submitted by the companies, company business models and momentum in the market, and Mosaic scores, CB Insights’ proprietary algorithm that measures the overall health and growth potential of private companies.

2021 Digital Health 150 Investment Highlights:

• Unicorns: 17 of the 150 companies (11%) are valued at or above $1B as of their latest funding rounds.

• Funding trends: In 2021 year-to-date (YTD), these 150 private companies have raised $9.2B in equity funding across 153 deals (as of 11/19/21).

• Mega-rounds: Since 2020, there have been 39 mega-round ($100M+) equity investments to this year’s Digital Health 150, with 31 (79%) of them taking place in 2021 YTD.

• Global representation: 23% of the 2021 Digital Health 150 are based outside the US. After the US, the UK is home to the most Digital Health 150 companies (9), followed by India (4). This year’s winners are based in 18 countries, including China, Israel, Nigeria, Germany, Argentina, and New Zealand.

• Top VC investor: General Catalyst is the most active investor in this year’s Digital Health 150 companies, having invested in 39 deals since 2016.

About CB Insights

CB Insights builds software that enables the world’s best companies to discover, understand, and make technology decisions with confidence. By marrying data, expert insights, and work management tools, clients manage their end-to-end technology decision-making process on CB Insights. To learn more, please visit www.cbinsights.com.

About Lumen

Lumen helps people improve their health and fitness through technology on the forefront of personalized nutrition and metabolism. Conceived and designed by twin sisters, physiology PhDs and Ironman winners, Lumen harnesses the power of our breath to measure metabolism, which is closely linked to weight, fitness and personal health. The Lumen device measures metabolism in a single breath, in less than a minute, which previously was only possible through an hour-long lab test. Available at Lumen.me, Lumen devices ship globally, with the app available on the Apple App Store and Google Play. Lumen is headquartered in Israel, with offices in the United States.

Link – https://www.lumen.me/

View source version on businesswire.com: https://www.businesswire.com/news/home/20211209005668/en/

Contacts

CB Insights Press Contact:
press@cbinsights.com

Lumen Press Contact:
Kyla Blumenfeld

Head of Media Relations

Kyla@lumen.me
+972547748599